- LZTFL1 suppresses gastric cancer cell migration and invasion through regulating nuclear translocation of β-catenin
Linbo Wang et al, 2014, Journal of Cancer Research and Clinical Oncology CrossRef - Human Epidermal Growth Factor Receptor 2 Status in Gastric Carcinomas with Distinctive Prevalent Cribriform Component
Antonio Ieni et al, 2018, Disease Markers CrossRef - Autophagy in advanced low- and high-grade tubular adenocarcinomas of the stomach: An ultrastructural investigation
Rosario Alberto Caruso et al, 2018, Ultrastructural Pathology CrossRef - Five biopsy specimens from the proximal part of the tumor reliably determine HER2 protein expression status in gastric cancer
Naoyuki Tominaga et al, 2016, Gastric Cancer CrossRef - HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and the American Society of Clinical Oncology
Angela N. Bartley et al, 2017, Journal of Clinical Oncology CrossRef - HER2 Heterogeneity in Personalized Therapy of Gastro-Oesophageal Malignancies: An Overview by Different Methodologies
Antonio Ieni et al, 2020, Journal of Personalized Medicine CrossRef - Alteration in key oncoprotein expression in gastric adenocarcinoma – An immunohistochemical study
Pragya Jain et al, 2023, Journal of Cancer Research and Therapeutics CrossRef - Autophagy-related Prognostic Signature in HER2 Positive Gastric Carcinomas
Antonio Ieni et al, 2022, Current Molecular Medicine CrossRef - HER2 Analysis in Sporadic Thyroid Cancer of Follicular Cell Origin
Rosaria Ruggeri et al, 2016, International Journal of Molecular Sciences CrossRef - Linifanib (ABT-869) Potentiates the Efficacy of Chemotherapeutic Agents through the Suppression of Receptor Tyrosine Kinase-Mediated AKT/mTOR Signaling Pathways in Gastric Cancer
Jing Chen et al, 2016, Scientific Reports CrossRef - Mast Cell Interaction with Neutrophils in Human Gastric Carcinomas: Ultrastructural Observations
Antonio Ieni et al, 2016, Analytical Cellular Pathology CrossRef - Biomarker analyses in REGARD gastric/GEJ carcinoma patients treated with VEGFR2-targeted antibody ramucirumab
Charles S Fuchs et al, 2016, British Journal of Cancer CrossRef - Incorporation of p-53 mutation status and Ki-67 proliferating index in classifying Her2-neu positive gastric adenocarcinoma
Ayesha Ahmed et al, 2018, Libyan Journal of Medicine CrossRef - HER2 Status in Premalignant, Early, and Advanced Neoplastic Lesions of the Stomach
A. Ieni et al, 2015, Disease Markers CrossRef - Discordance Rate of HER2 Status in Primary Gastric Carcinomas and Synchronous Lymph Node Metastases: A Multicenter Retrospective Analysis
Antonio Ieni et al, 2014, International Journal of Molecular Sciences CrossRef - HER2Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma
Angela N. Bartley et al, 2016, American Journal of Clinical Pathology CrossRef - HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline Summary From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology
Angela N. Bartley et al, 2017, Journal of Oncology Practice CrossRef - Impact of HER2 expression on outcome in gastric cancer patients with liver metastasis
H. Jiang et al, 2017, Clinical and Translational Oncology CrossRef - HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology
Angela N. Bartley et al, 2016, Archives of Pathology & Laboratory Medicine CrossRef - Real-world association of HER2/ERBB2concordance with trastuzumab clinical benefit in advanced esophagogastric cancer
Stacey M Stein et al, 2021, Future Oncology CrossRef - Systemic therapy for gastric cancer: Perioperative strategies and beyond
Christopher Cann et al, 2022, Journal of Surgical Oncology CrossRef